The COAG and EU-PACT Trials: What is the Clinical Benefit of Pharmacogenetic-Guided Coumarin Dosing During Therapy Initiation?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|14|7|841-848

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.14, Iss.7, 2014-08, pp. : 841-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials of antibody therapy

By Glennie M.J.   Johnson P.W.M.  

Immunology Today, Vol. 21, Iss. 8, 2000-08 ,pp. : 403-410

Elsevier

Access to resources Recommend Favorite

Clinical experience of pediatric kidney transplantation: what is the benefit?

By Seki T.   Koyanagi T.   Chikaraishi T.   Takeuchi I.   Kanagawa K.   Harada H.   Togashi M.   Hirano T.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1822-1823

Elsevier

Access to resources Recommend Favorite

Promises and pitfalls of anti-angiogenic therapy in clinical trials

By McCarty M.F.   Liu W.   Fan F.   Parikh A.   Reimuth N.   Stoeltzing O.   Ellis L.M.  

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Towards More Successful Gene Therapy Clinical Trials for &bgr;-Thalassemia

By  

Current Molecular Medicine, Vol. 13, Iss. 8, 2013-09 ,pp. : 1314-1330

Bentham Science Publishers

Access to resources Recommend Favorite

Sublingual immunotherapy: Dosing in relation to clinical and immunological efficacy

By Larenas-Linnemann Désirée E.  

Allergy and Asthma Proceedings, Vol. 29, Iss. 2, 2008-03 ,pp. : 130-139

OceanSide Publications, Inc

Access to resources Recommend Favorite